Home About Us Products Clinical Trials News Investors Contact Advisory Board The Company is advised by a number of key opinion leading scientists and clinicians, particular to each of our therapeutic programmes and the particular scientific and medical expertise required at the time. Their role is to advise on the clinical development of our stem cell therapies and to review and monitor progress with our therapeutic programmes as they progress into and through their clinical development phase. Additionally, the Company has established a Scientific Advisory Board (SAB), which is chaired by Dr Mike Owen and is composed of leading academics and industry executives with a world-class breadth of expertise across the Company’s areas of operation. The SAB will provide insight and counsel across ReNeuron’s therapeutic programmes and broader research and development activities. Its role is to advise the Company on scientific matters relating to its research and clinical development strategy. This includes the future direction of cell therapy, links to academic, regulatory and industrial organisations and relationships with peer companies and government bodies on a global basis. The SAB comprises the following members: Dr Mike Owen Mike Owen’s career in biotech, the pharmaceutical industry and academia spans almost 40 years. He serves as a director of Zealand Pharma, Ossianix Inc, BlinK Biomedical SAS and Avacta plc and, in addition to ReNeuron, is a member of the Scientific Advisory Boards of Kymab Ltd and the CRT Pioneer Fund LP, and the investor advisory bo... Read more... Professor Sir Colin Blakemore Colin Blakemore, FMedSci, HonFRCP, FRS, is Professor of Neuroscience & Philosophy at the School of Advanced Study, University of London, and Emeritus Professor of Neuroscience at Oxford. He studied Medical Sciences at Corpus Christi College, Cambridge, and did a PhD at the University of California, Berkeley. He taught at Cambrid... Read more... Dr Marie Csete Marie Csete received her undergraduate music degree from Princeton University, followed by an MD from Columbia University, College of Physicians & Surgeons. She is board certified in anesthesiology with subspecialty certification in critical care. Her academic career focused on optimising the perioperative management of liver tr... Read more... Dr Stephen J. Gould Stephen J. Gould, Ph.D., is a professor of biological chemistry at the Johns Hopkins University School of Medicine. Dr. Gould’s research focuses on the molecular mechanisms behind the biogenesis and uptake of exosomes and microvesicles (EMVs), tiny vesicles secreted by animal cells. Since they have the same topology as the cells the... Read more... Professor Trevor Jones CBE Professor Trevor Jones was the founder Chairman of ReNeuron and is the Chairman of Simbec-Orion Research Ltd (UK). Until March 2015 he was a Director of Allergan Inc (USA), and formerly a main board director of The Wellcome Foundation, where he was responsible for R&D including the development of AZT (HIV/AIDS), Zovirax (Herpes)... Read more... Dr Thomas Lönngren Thomas Lönngren is the former Executive Director of the European Medicines Agency, EMA and he previously served with the Swedish Board of Health and Welfare as Director of Operations and later Deputy Director General at the Swedish Medical Products Agency (MPA). Thomas established the EMA from a relatively small-unknown agency in 20... Read more... Professor Robert MacLaren Professor Robert MacLaren is Professor of Ophthalmology at the University of Oxford, where he directs research into developing new clinical treatments for blindness, using stem cells, gene therapy and electronic retinal implants. In 2016 he performed the world’s first operation inside the human eye using a remotely controlled robot.... Read more... Professor Chris Mason Chris Mason is Professor of Regenerative Medicine Bioprocessing in the Advanced Centre for Biochemical Engineering, University College London working on the clinical translation and commercialization of cell and gene therapies. He has a multidisciplinary track record, spanning R&D, clinical medicine, bioprocessing, regulation, h... Read more... Dr Mahendra S. Rao Developmental Neurobiology from the California Institute of Technology. Mahendra Rao is internationally known for his research involving human embryonic stem cells (hESCs) and other somatic stem cells and has worked in the stem cell field for more than twenty years with stints in academia, government and regulatory affairs and indus... Read more... Dr Lee L. Rubin Lee Rubin has a broad experience in both academia and industry, particularly in the realms of cell-based assays and drug discovery. Prior to joining Harvard, he was Chief Scientific Officer of Curis, Inc., a Cambridge-based biotechnology company, where his group identified the first small molecule regulators of the hedgehog signalli... Read more... Dr José-Alain Sahel Dr José-Alain Sahel is the chair of the Department of Ophthalmology at the University of Pittsburgh School of Medicine, of the UPMC Eye Center, and the Eye and Ear Foundation Endowed Chair of Ophthalmology. He founded and still heads the Institut de la Vision (Sorbonne Université-Inserm-CNRS) in Paris, one of the largest Vision Rese... Read more... Dr John Sinden BA MA Ph.D Dr Sinden is a scientific co-founder of ReNeuron and from 1998 to 2019 was its Chief Scientific Officer. Prior to cofounding ReNeuron and becoming its first employee, he was Reader in Neurobiology of Behaviour at the Institute of Psychiatry at Kings College London. He graduated in Psychology from the University of Sydney and ... Read more... Dr Sally Temple Dr Sally Temple is the Scientific Director of the Neural Stem Cell Institute in New York. She leads a team of 30 researchers focused on using neural stem cells to develop therapies for eye, brain, and spinal cord disorders. In 1989, she discovered that the embryonic mammalian brain contained a rare stem cell that could be activated ... Read more... Section: About Us About ReNeuron Board of Directors Senior Management Advisory Board Working at ReNeuron Patents Subscribe here for our Press Releases: The information collected will be used to send you the information you have requested and to provide information that may be useful to you. ReNeuron may share non-personal aggregate statistics (group) data about ReNeuron’s website visitors with partners or other parties. However, ReNeuron will not sell or share any information about individual users. Please ensure you have read the full contents of our Privacy Notice before continuing. If you agree to your information being used in this way, please tick the box: I agree Click here © ReNeuron Group plc 2021 All rights reserved Website design by Carr Kamasa Design Privacy Notice Disclaimer